"The addition of Tyvek 40L to our family of Tyvek styles for medical and pharmaceutical packaging is the latest example of our long-standing and ongoing commitment to making a world of greater good possible,” said Margaret Pyers, global business leader for DuPont Tyvek Medical and Pharmaceutical Packaging. “Tyvek 40L fills a previously unmet need for a better material to package lightweight, low-risk Class I and IIa devices, especially in emerging Asian markets. We are proud to continue our long tradition of meeting marketplace needs with products that provide protection so people can accomplish bigger things.”
Tyvek 40L features many of the same benefits that have made Tyvek a standard of excellence for medical packaging since 1972, including maintaining sterility until point of use (even under rigorous conditions); low particulate generation; clean peel; puncture and tear resistance during handling and transportation, even in high humidity; and compatibility with most major sterilization methods. This lighter weight Tyvek, which offers excellent performance with ethylene oxide (EO) and gamma radiation sterilization, can be readily distinguished by its embossed, linen-like appearance.
When compared to reinforced, heavy basis weight papers, Tyvek 40L shows better strength and far superior breathability. Tyvek 40L also peels cleanly when opening the package, even if the package is uncoated and sealed to a peelable film. With its very low basis weight, Tyvek 40L provides excellent value and packaging source reduction opportunities to support sustainability efforts.
In addition to offering a range of microbial barrier products, which now includes Tyvek 1073B, Tyvek 1059B, Tyvek 2FS and new Tyvek 40L, the DuPont Medical and Pharmaceutical Packaging team provides technical support to medical device manufacturers (MDMs) around the world, sharing information and expertise on topics ranging from industry standards and regulatory compliance to technical issues and quality. Members of the team also play key roles in industry associations and standards-setting organizations, such as Association for the Advancement of Medical Instrumentation (AAMI), European Committee for Standardization (CEN), International Organization for Standardization (ISO) and Standardization Administration of the People’s Republic of China (SAC), to name a few.
For more than 45 years, Tyvek has helped to protect the health of millions of patients worldwide and to reduce costs in the health care setting by maintaining sterility of medical devices and supplies to the point of use. Recognized as a standard of excellence in health care packaging, this advanced material is used in virtually every form of sterile medical packaging, as well as a wide variety of pharmaceutical packaging applications.
DuPont Protection Solutions, a business unit of DowDuPont Specialty Products Division, is a global leader in products and solutions that protect people, structures, and the environment. DuPont Kevlar helps protect law enforcement officers, military personnel, athletes and astronauts; DuPont Nomex helps protect firefighters, industrial workers and race car drivers, as well as mass transit and wind energy systems; DuPont Tyvek helps protect chemical industrial workers, as well as sterile medical devices and building construction; and DuPont Corian resists the growth of bacteria to help protect hospital patients against infection.
DowDuPont Specialty Products, a division of DowDuPont, is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. The company applies diverse science and expertise to help customers deliver innovations in various markets including electronics, transportation, building and construction, health and wellness, food, and worker safety. DowDuPont intends to separate the Specialty Products Division into an independent, publicly traded company.